Baxter International Inc. (BAX)
28.39
0.55 (1.98%)
At close: Apr 14, 2025, 3:22 PM
1.98% (1D)
| Bid | 28.39 |
| Market Cap | 14.56B |
| Revenue (ttm) | 12.86B |
| Net Income (ttm) | -649M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -44.36 |
| Forward PE | 13.17 |
| Analyst | Hold |
| Ask | 28.4 |
| Volume | 2,522,059 |
| Avg. Volume (20D) | 5,949,124.9 |
| Open | 28.38 |
| Previous Close | 27.84 |
| Day's Range | 28.06 - 28.70 |
| 52-Week Range | 26.25 - 41.18 |
| Beta | 0.65 |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nu...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Oct 27, 1981
Employees 38,000
Stock Exchange NYSE
Ticker Symbol BAX
Website https://www.baxter.com
Analyst Forecast
According to 9 analyst ratings, the average rating for BAX stock is "Hold." The 12-month stock price forecast is $40, which is an increase of 40.89% from the latest price.
Stock ForecastsNext Earnings Release
Baxter International Inc. is scheduled to release its earnings on May 1, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+8.5%
Baxter International shares are trading higher aft...
Unlock content with
Pro Subscription
5 months ago
-3.88%
Baxter International shares are trading lower after the company issued FY24 adjusted EPS guidance slightly below analyst expectations.
